Skip to content

effect of medication self-management intervention based on the 5A model on medication adherence and quality of life of myocardial infarction patients

Investigating the effect of medication self-management intervention based on the 5A model on medication adherence and quality of life of myocardial infarction patients hospitalized in Jahrom medical sciences hospitals

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231227060543N1
Enrollment
66
Registered
2024-01-17
Start date
2024-01-21
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial infarction. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction

Interventions

Intervention 1: "Intervention group" After each patient is randomly assigned in two Test and control groups, the demographic information questionnaire, the morrisky drug compliance questionnaire, the

Sponsors

Jahrom University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Literacy Age range between 30 and 65 years Diagnosis of myocardial infarction by a doctor Have no previous history of myocardial infarction Hospitalized patients for at least three days Having one of the diseases of blood pressure diabetes or hyperlipidemia that they have taken for at least six months The ability to perform self-care, especially the consumption and adherence to the medication regimen Ability to prepare and buy prescribed drugs The patient's non-participation in other educational plans of self-care methods

Exclusion criteria

Exclusion criteria: Patient death during the study Non-participation of the patient in telephone follow-up and questionnaire completion

Design outcomes

Primary

MeasureTime frame
Medication adherence score in Morisky questionnaire. Timepoint: Measurement of medication adherence at the beginning of the study (before the start of the intervention) and six weeks after the start of the intervention. Method of measurement: Moriski medication adherence questionnaire.

Secondary

MeasureTime frame
Quality of life score. Timepoint: At the beginning of the study (before the start of the intervention) and six weeks after the start of the intervention. Method of measurement: Mac New Quality of Life Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahsa Heydari Aghcheghlo

Jahrom University of Medical Sciences

mahsa.206772@gmail.com007154372252

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026